Gastroenterology
News
Drugs
Xagena Medicine
Xagena.net
FGF15 controls the production of bile acid
Oxycodone seems to be more effective than Morphinei in vsceral pain
Crohn's disease: enhancing innate immunity improves symptoms
Tysabri Phase III trial meets primary endpoint in Crohn’s disease
MLN02 induces remission in ulcerative colitis
GM-CSF decreases severity and improves quality of life in patients with Crohn's disease
High-grade colorectal adenomas: UDCA may reduce recurrence
Ulcerative colitis: Remicade appears effective
Tegaserod shows promise in the treatment of upper gastrointestinal disorders
Celiac disease linked to timing of gluten exposure
Crohn's disease: Xifaxan as a potential treatment option
Prevention of traveler's diarrhea: Xifaxan
Sleep disturbance associated with GERD
Obesity: new surgical options
Inflammatory bowel diseases: biological therapies
Efficacy of the treatment with Humira in patients with Crohn’s disease
Nexium may reduce upper GI symptoms in patients using NSAIDs
Elderly: Mediterranean diet increases survival
Next Pages
1
[
2
]
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions